Inceptive
L7 · Models
scientific & causal modelsstartupprivateseries A
Closed weight
Inceptive trains generative models for designing RNA medicines, applying large-scale sequence modelling to reason jointly about RNA structure, function and manufacturability. It moved AI-designed RNA candidates into experimental and pharmaceutical development across 2024-2026.
Ecosystem functionA narrow specialist applying generative sequence models to RNA, a modality most biology labs skip.
Business modelRNA therapeutic development
Revenue—
Valuation—
Last round$100Mled by NVIDIA and Andreessen Horowitz · 2023
Sources · 1 ↓
Suggest an editLast verified 2026-08-07